Akebia Therapeutics, Inc. ($AKBA)
Filing Information
| Accession Number | 0001619834-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
67,658
Total Value
$94,044.62
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Medical Officer | Common Stock | โ | Feb 2, 2026 | Sale | 21,582 | $1.39 | $29,998.98 | 994,508 | Direct | โ | View Details | |
SVP, Chief Medical Officer | Common Stock | โ | Feb 2, 2026 | Sale | 25,375 | $1.39 | $35,271.25 | 969,133 | Direct | โ | View Details | |
SVP, Chief Medical Officer | Common Stock | โ | Feb 2, 2026 | Sale | 20,701 | $1.39 | $28,774.39 | 948,432 | Direct | โ | View Details |